High linearity for a wider input voltage range and low-power operation of the operational transconductance amplifier (OTA) are indispensable parameters for health care applications, which require high quality and accurate signal conditioning. However, achieving low-power operation along with high linearity at low supply voltages is challenging for OTA using conventional low-power and linearization techniques. This paper proposes an OTA based on a cross-coupled gate-driven quasi-floating bulk (CGDQFB) MOSFET and source-degenerated linearization techniques, which works at a supply of ±0.5 V. The post-layout simulations of the proposed OTA are performed in the 180 nm standard CMOS process, which shows a transconductance of 0.321 μS, an output impedance of 331 MΩ, an input impedance of 897 GΩ, a DC gain of 40.54 dB, a gain-bandwidth of 0.145 MHz, a total harmonic distortion (THD) of 51.09 dB for an input voltage range of 626.7 mV at a frequency of 100.39 Hz, and a power consumption of 0.45 μW. The proposed OTA shows an input common mode range of −0.34 to 0.4 V, an output voltage swing of −0.34 to 0.34 V, a common mode rejection ratio of 91.08 dB, and a consumption area of 23 965.92 µm2. Furthermore, with 200 Monte Carlo iterations, the proposed OTA shows variability for gain and THD of 0.003 and 0.036, respectively. The proposed CGDQFB OTA is a suitable contender for conditioning bio-signals used in health care applications.